Shockwave Therapy for Tennis Elbow

Less painful than surgery

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

TUESDAY, March 18, 2003 (HealthDayNews) -- The OssaTron high energy orthopedic shockwave device has been approved by the U.S. Food and Drug Administration for treatment of chronic tennis elbow, medically known as lateral epicondylitis.

The device is already agency-approved for heel pain. Manufacturer HealthTronics Surgical Services Inc. says it requires only one treatment, allows for faster recovery, and is less painful than surgery to correct tennis elbow.

FDA approval was based on a 225-patient clinical trial, in which 90 percent of participants benefited from the treatment and 64 percent reported excellent or good outcomes, HealthTronics says in a prepared statement.

Here is the company press release announcing the approval. For more about tennis elbow, visit the National Library of Medicine.


Last Updated: